EVETERACETAM VS SODIUM VALPROATE
Not Applicable
- Conditions
- Health Condition 1: G409- Epilepsy, unspecified
- Registration Number
- CTRI/2020/09/027792
- Lead Sponsor
- government medical college and hospital aurangabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All children with age two years and above diagnosed with generalized epilepsy attending
Pediatric OPD and IPD at tertiary care hospital
Exclusion Criteria
1 children with age less than 2 yearâ??s.
2 children with already on anti-epileptic drug
3 children with epilepsy syndrome
4 children with genetic disorder
5 children with chronic liver disease
Or chronic kidney disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare effect of oral levetiracetram v/s soduim valproate as first line monotherapy in newly diagnosed generalised epilepsy in children <br/ ><br> <br/ ><br>Timepoint: 18 months
- Secondary Outcome Measures
Name Time Method 1.To study the side effect of levetiracetam and sodium valproateTimepoint: 18 months